Madjed, Jembran M.

HRN: 26-13-77  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/05/2026
03/11/2026
IV
100mg
Q24
PCAP C
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines